BioSpace News Archive

Genetown

Hemab Therapeutics Presents New Data on HMB-001 for the Treatment of Glanzmann Thrombasthenia and Other Bleeding Disorders at 2022 ISTH Congress

Hemab Therapeutics presented new pre-clinical data on HMB-001, a novel bispecific antibody poised to become the first-ever prophylactic treatment option for Glanzmann Thrombasthenia and other rare bleeding conditions.

July 13, 2022
·
4 min read
Drug Development

Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery

Pluristem Therapeutics Inc., a leading biotechnology company, announced topline results from its multinational double-blind, placebo-controlled phase III study.

July 13, 2022
·
8 min read
Business

Merck and Orion Announce Global Collaboration for the Development and Commercialization of ODM-208, an Investigational Steroid Synthesis Inhibitor for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck, known as MSD outside the United States and Canada, and Orion Corporation announced a global development and commercialization agreement for Orion’s investigational candidate ODM-208 and other drugs targeting cytochrome P450 11A1, an enzyme important in steroid production.

July 13, 2022
·
6 min read
Drug Development

Newly Published Phase 3 Study in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

SaNOtize Research & Development Corp. and Glenmark Pharmaceuticals Limited published results of a Phase 3 clinical trial in The Lancet Regional Health Southeast Asia, illustrating the effectiveness of nitric oxide nasal spray for the treatment of adult patients with COVID-19.

July 13, 2022
·
5 min read
Deals

U.S. Alliance Pharma Acquires U.K.-based LGC’s Drug Development Solutions (DDS) Business

Alliance Pharma, a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, closed on the purchase of Drug Development Solutions, a U.K.-based bioanalytical and material science testing contract research organization, from LGC.

July 13, 2022
·
4 min read
Biotech Beach

Biolase Announces Training Initiative With Einstein Healthcare Network’s General Dentistry Residency Program

BIOLASE, Inc., the global leader in dental lasers, announced a pilot program with Einstein Healthcare Network’s residency in General Dentistry to train General Dentist residents in the use of Waterlase dental laser technology.

July 13, 2022
·
5 min read
Drug Development

Nuvalent to Present New NVL-655 Preclinical Data and ARROS-1 Trial in Progress Poster for NVL-520 at IASLC 2022 World Conference on Lung Cancer Annual Meeting

Nuvalent, Inc. announced it will present two posters for its parallel lead programs, NVL-655, an ALK-selective inhibitor and NVL-520, a ROS1-selective inhibitor, at the IASLC 2022 World Conference on Lung Cancer Annual Meeting taking place August 6-9, 2022 in Vienna, Austria.

July 13, 2022
·
8 min read
Business

Myovant Sciences to Host First Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. Eastern Time on July 27, 2022

Myovant Sciences, announced it will host a webcast and conference call to discuss corporate updates and financial results for its first fiscal quarter, ended June 30, 2022.

July 13, 2022
·
2 min read
Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections

Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections.

July 13, 2022
·
2 min read
Drug Development

Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program

XHANCE is the first and only nasal medication ever shown in Phase 3 controlled trials to reduce exacerbations for patients with chronic sinusitis.

July 13, 2022
·
12 min read